Am I eligible for the program?

Print

You may be eligible for our free prescription program if you meet the requirements below:

You have been prescribed a Johnson & Johnson operating company donated medication
You meet the eligibility income requirements for the medication(s). You may view the income requirements below
You don’t have insurance or medicine is not covered
- Some patients with Medicare Prescription Drug Coverage (Part D) who cannot afford their medicines and who meet certain financial criteria may also be eligible for assistance
  - A report from your pharmacy or an Explanation of Benefits (EOB) statement from your insurer that shows your out-of-pocket costs for the current year can be requested and may be submitted with your application. In order to qualify for the program, you must spend 4% or more of your gross annual income on prescription drugs.
You live in the United States or a U.S. Territory
You are being treated by a U.S. licensed doctor as an outpatient

Medication

BALVERSA^®
(erdafitinib) Tablets

DARZALEX^®
(daratumumab) Injection for intravenous infusion

DARZALEX FASPRO^™
(daratumumab and hyaluronidase-fihj), injection for subcutaneous use

EDURANT^{® 1}
(rilpivirine) Tablets

ELMIRON^®
(pentosan polysulfate sodium) Capsules

ERLEADA^®
(apalutamide) Tablets

HALDOL^® Decanoate^†
(haloperidol) IM Injection Only

IMBRUVICA^®
(ibrutinib) Capsules/Tablets

INTELENCE^{® 1}
(etravirine) Tablets

INVEGA HAFYERA^{™ †}
(paliperidone palmitate) Extended-Release Injectable Suspension

INVEGA SUSTENNA^{® †}
(paliperidone palmitate) Extended-Release Injectable Suspension

INVEGA TRINZA^®^†
(paliperidone palmitate) Extended-Release Injectable Suspension

INVOKAMET^®^{† 1}
(canagliflozin/metformin HCI) Tablets

INVOKAMET^® XR^{† 1}
(canagliflozin/metformin HCI) Tablets

INVOKANA^®¹
(canagliflozin) Tablets

MONOVISC^®
(high molecular weight hyaluronan) Injection

ORTHOVISC^®
(high molecular weight hyaluronan) Injection

PONVORY^™
(ponesimod) Tablets

PREZCOBIX^®¹
(darunavir 800mg/cobicistat 150mg) Tablets

PREZISTA^{® 1}
(darunavir) Tablets/Oral Suspension

PROCRIT^{® †}
(epoetin alfa) Injection

REMICADE^{® †}
(infliximab) IV Infusion

RISPERDAL CONSTA^{® †}
(risperidone) Long-Acting Injection

RYBREVANT^®
(amivantamab-vmjw) Injection

SIMPONI^{® †}
(golimumab) Injection

SIMPONI ARIA^®^†
(golimumab) IV Infusion

SIRTURO^{® †}
(bedaquiline) Tablets

SPORANOX^{® †}
(itraconazole) Capsules

SPORANOX^{® †}
(itraconazole) Oral Solution

SPRAVATO^{® †}
(esketamine) Nasal Spray, for intranasal use, CIII

STELARA^®
(ustekinumab) Injection, for subcutaneous or intravenous use

SYMTUZA^{® †}
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets

TREMFYA^®
(guselkumab) Injection, for subcutaneous use

XARELTO^{® † 1}
(rivaroxaban) Tablets or Oral Suspension

YONDELIS^®
(trabectedin) Injection for intravenous infusion

ZYTIGA^®
(abiraterone acetate) Tablets